MADISON HEIGHTS, Mich.
April 26, 2012
/PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE Amex: INFU), the leading national provider of infusion pumps and related services for the healthcare industry, today announced that its Board of Directors has named Director
Ryan J. Morris
, 27, Executive Chairman. Morris led a shareholder activist movement that began in November of 2011 when the stock was trading at approximately
per share. It culminated in a major overhaul of the Company's governance earlier this week as former Chairman and Chief Executive Officer
and four other directors resigned.
The board also named
, Portfolio Manager of Nadel and Gussman, LLC, as Lead Independent Director. He and Morris joined the InfuSystem board this week, along with other new members
. Singh was also named Interim CEO. Two directors,
, will continue their roles on the board.
The Company said that its Annual Meeting of Shareholders, originally scheduled to be held on
May 11, 2012
has been rescheduled for May 25. InfuSystem stockholders of record at the close of business on
April 30, 2012
will be entitled to receive notice about and vote at the meeting. Further details regarding the meeting will be included in the Company's proxy statement, which InfuSystem expects to mail to stockholders shortly.
"Our prime mandate is to create value for all shareholders," says new Executive Chairman Morris. "Further, we believe that our personal economic fates should continue to be entirely tied to performance. Accordingly, new board members will be compensated solely in stock options.